COPPELL, Texas--(BUSINESS WIRE)--Mannatech®, Incorporated (NASDAQ: MTEX), the founder of the M5MSM (Mission 5 MillionSM) Foundation, the pioneer of Glyconutrition and the global innovator of naturally-sourced supplements based on Real Food Technology® solutions, announced the results of its charitable giving to the M5M Foundation during 2015, which amounted to more than $1 million.
In total, these donations enabled more than 17 million servings of the company’s nutrient-dense PhytoBlend™ product to be given to more than 48,000 children in need in nine countries around the world on a daily basis.
Donations from Mannatech to the M5M Foundation are triggered directly from individual product orders. When anyone orders nutritional products for themselves from Mannatech, they are also helping fight global malnutrition.
“It is an honor to partner with the M5M Foundation to help combat childhood malnutrition; and in 2015 we made great strides in that effort,” said Mannatech CEO and President and M5M Foundation Board Member, Al Bala. “The Mission 5 Million cause is the heart behind so many Mannatech businesses. This year we will be increasing our efforts by beginning clinical trials on PhytoBlend to gain additional insight into how it improves quality of life. We will also enhance the PhytoBlend formula to contain even more nutrients. I look forward to seeing this movement gain more ground in 2016 with Mannatech’s continued support.”
Mannatech Associates and vendors will be invited to attend an exclusive M5M gala at the company’s global MannaFestSM event in Dallas, Texas on April 9. Associates will also learn about opportunities to visit M5M partners in other countries and deliver PhytoBlend.
The M5M Foundation is an independent 501c (3) non-profit charity organization. It officially launched on January 1, 2015 in partnership with Mannatech to help link five million consumers of Mannatech’s Real Food Technology supplementation with five million children in need. The M5M Foundation acts as an ambassador for these children by delivering the gift of better nutrition which Mannatech provides through its PhytoBlend product.
Mannatech’s PhytoBlend powder is designed to help in the fight against global malnutrition by providing children in need with valuable, supplemental nutrition that mixes easily into the foods they’re already eating. PhytoBlend powder contains nutrients from plants and other natural sources, allowing children to receive standardized and nutritionally beneficial amounts of vitamins, minerals and phytonutrients in a natural form unique to the industry.
“I couldn’t be more proud of the M5M Foundation’s accomplishments in its first year,” said M5M Executive Director, Sarah Bowen. “With Mannatech’s help, we were able to efficiently distribute 41 percent more PhytoBlend than previous years due to a new structure and streamlined process that we have found to be more effective. I can’t wait to see what we can do together in this next year, and I look forward to reaching even more children with help from all of our partners.”
For more information on Mannatech’s products, or to explore its business opportunity, visit Mannatech.com.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, Spain, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia, Hong Kong and Colombia. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “believe,” “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.